Action of aluminum on high voltage-dependent calcium current and its modulation by ginkgolide B

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 539-545

  Chen, Lei ^a   Liu, Chang Jin ^a   Tang, Ming ^a   Li, Ai ^a   Hu, Xin Wu ^a   Du, Yi Mei ^a   Shen, Jing Jing ^a   Lu, Yong Li ^a   Heschler, Jurgen ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Aluminum; Ginkgolide B; Hippocampus; Patch clamp technique; Voltage dependent calcium channels

Indexed keywords

ADENYLATE CYCLASE; ALUMINUM; ALUMINUM CHLORIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; FORSKOLIN; GINKGOLIDE B; ION CHANNEL; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; COMPLEX FORMATION; DRUG MECHANISM; HIPPOCAMPUS; NERVE INJURY; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PATCH CLAMP; PYRAMIDAL NERVE CELL; RAT;

ALUMINUM COMPOUNDS; ANIMALS; CALCIUM CHANNELS; CELL SEPARATION; CHLORIDES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FORSKOLIN; GINKGO BILOBA; GINKGOLIDES; HIPPOCAMPUS; ISOQUINOLINES; LACTONES; NEURONS; NEUROPROTECTIVE AGENTS; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 18744404285     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00073.x     Document Type: Article

References (24)

1. Tokutake S, Nagase H, Morisaki S, Oyanagi S. Aluminium detected in senile plaques and neurofibrillary tangles is contained in lipofuscin granules with silicon, probably as aluminosilicate. Neurosci Lett 1995; 185: 99-102.
2. Wisniewski HM. Aluminum, tau protein, and Alzheimer's disease. Lancet 1994; 344: 204-5.
3. Gilbert ME, Shafer TJ. In vitro exposure to aluminum does not alter long-term potentiation or glutamate release in rat hippocampal slices. Neurotoxicol Teratol 1996; 18: 175-80.
4. Platt B, Carpenter DO, Busselberg D, Reymann KG, Riedel G. Aluminum impairs hippocampal long-term potentiation in rats in vitro and in vivo. Exp Neurol 1995; 134: 73-86.
5. Zou BD, Xiao HM, Zhang ZD, Li A. Effect of aluminum on evoked potential on hippocampal CA3 area in rats. J Tongji Med Univ 1998; 27: 15-18.
6. Matyja E. Aluminum enhances glutamate-mediated neurotoxicity in organotypic cultures of rat hippocampus. Folia Neuropathol 2000; 38: 47-53.
7. Platt B, Büsselberg D. Actions of aluminium on voltage-activated calcium channel currents. Cell Mol Neurobiol 1994; 14: 819-29.
8. A receptors by aluminum. J Neurophysiol 1998; 80: 755-61.
9. Platt B, Haas H, Büsselberg D. Aluminum reduces glutamate-activated currents of rat hippocampal neurons. Neuroreport 1994; 5: 2329-32.
10. i in guinea pig ischemic ventricular myocytes. Acta Physiol Sin 2003; 55: 24-8.
11. Bastianetto S, Quirion R. EGb 761 is a neuroprotective agent against beta-amyloid toxicity. Cell Mol Biol 2002; 48: 693-7.
12. Wu XF, Wang QJ, Lou FC. Protective effect of Ginkgolides on rat focal brain ischemia. J China Pharm Univ 2001; 32: 141-5.
13. Xu CQ, Zhang ZM, Xia ZL, Wu CH, Zhou PA. Acute isolation and identification of CA1 pyramidal neurons in hippocampus of rats. Chin J Appl Physiol 1999; 15: 189-91.
14. Savory J, Herman MM, Ghribi O. Intracellular mechanisms underlying aluminum-induced apoptosis in rabbit brain. J Inorg Biochem 2003; 97: 151-4.
15. Deisseroth K, Heist EK, Tsien RW. Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 1998; 392: 198-202.
16. Morgan SL, Teyler TJ. VDCCs and NMDARs underline two forms of LTP in CA1 hippocampus in vivo. J Neurophysiol 1999; 82: 736-40.
17. Kavalali ET, Hwang KS, Plummer MR. cAMP-dependent enhancement of dihydropyridine-sensitive calcium channel availability in hippocampal neurons. J Neurosci 1997; 17: 5334-48.
18. Macdonald TL, Martin RB. Aluminum ion in biological systems. Trends Biochem Sci 1988; 13: 15-19.
19. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. A placebo-controlled, doubled-blind, randomized trial of an extract of Ginkgo biloba for dementia. J Am Med Assoc 1997; 278: 1327-32.
20. Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Biochem Pharmacol 2002; 63: 1241-9.
21. Bastianetto S, Zheng WH, Quirion R. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 2000; 74: 2268-77.
22. Zhu L, Wu J, Liao H, Gao J, Zhao XN, Zhang ZX. Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Acta Pharmacol Sin 1997; 18: 344-7.
23. Kondratskaya EL, Lishko PV, Chatterjee SS, Krishtal OA. BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. Neurochem Int 2002; 40: 647-53.
24. Chatterjee SS, Kondratskaya EL, Krishtal OA, Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. Pharmacopsychiatry 2003; 36: S68-77.